<DOC>
	<DOCNO>NCT02565693</DOCNO>
	<brief_summary>There mark lack evidence optimal prevention ischaemic stroke patient atrial fibrillation recent intracerebral haemorrhage ( ICH ) treatment oral anticoagulation . These patient currently treat vitamin K antagonist , antiplatelet drug , antithrombotic treatment , depend personal institutional preference . Treatment direct oral anticoagulant like apixaban might attractive alternative term low risk recurrent ICH , time effective prevention ischaemic stroke . This study aim obtain reliable estimate rate vascular death non-fatal stroke patient atrial fibrillation recent anticoagulation-associated intracerebral haemorrhage treat apixaban versus treat antiplatelet drug antithrombotic drug . This study multi-centre , phase II , randomise , open-label clinical trial blind outcome assessment design .</brief_summary>
	<brief_title>Apixaban Versus Antiplatelet Drugs Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage Patients With Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Carbaspirin calcium</mesh_term>
	<criteria>Intracerebral haemorrhage ( include include isolated spontaneous intraventricular haemorrhage ) , document CT MRI , treatment anticoagulation ( VKA , direct thrombin inhibitor , factor Xa inhibitor , ( low molecular weight ) heparin therapeutic dose ) . The haemorrhage occur 7 90 day randomization . Diagnosis ( paroxysmal ) nonvalvular AF , document electrocardiography . A CHA2DS2VASc score ≥ 3 . Score modify Rankin scale ( mRS ) 4≤4 . Equipoise regard optimal medical treatment prevention stroke . Age ≥ 18 year . Written informed consent patient legal representative Conditions atrial fibrillation patient require longterm anticoagulation A different clinical indication use antiplatelet drug even treat apixaban , clopidogrel recent coronary stenting . Mechanical prosthetic heart valve ( biological prosthetic heart valve allow ) rheumatic mitral valve disease . Serious bleed event previous 6 month , except intracerebral haemorrhage . High risk bleeding ( e.g. , active peptic ulcer disease , platelet count &lt; 100,000.mL1 haemoglobin level &lt; 6.2 mMol.L1 , ischaemic stroke previous 7 day ( patient eligible thereafter ) , document haemorrhagic tendency , blood dyscrasia ) . Current alcohol drug abuse . Life expectancy less 1 year . Severe renal insufficiency ( serum creatinine level 221 μmol per liter calculate creatinine clearance &lt; 15 ml per minute ) . Alanine aminotransferase aspartate aminotransferase level great 2 time upper limit normal range total bilirubin 1.5 time upper limit normal range , unless benign causative factor ( e.g . Gilbert 's syndrome ) know identify . Allergy apixaban . Use strong cytochrome P450 3A4 ( CYP3A4 ) Pglycoprotein ( Pgp ) inhibitor ( e.g . systemic azoleantimycotics ketoconazole HIV protease inhibitor ritonavir ) . Pregnancy breastfeed . Women childbearing potential : woman begin menstruation postmenopausal otherwise permanently unable conceive . A postmenopausal woman define woman age 45 menstrual period least 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>